CONTROVERSIES IN THE MANAGEMENT OF RETROMOLAR TRIGONE CARCINOMAAYAD, Tareck; GUERTIN, Louis; SOULIERES, Denis et al.Head & neck. 2009, Vol 31, Num 3, pp 398-405, issn 1043-3074, 8 p.Article

Treatment with hydroxyurea in a patient compound heterozygote for a high oxygen affinity hemoglobin and β-thalassemia minorGAUDREAU, Pierre-Olivier; XIAODUAN WENG; COURNOYER, Ghislain et al.American journal of hematology. 2009, Vol 84, Num 11, pp 766-768, issn 0361-8609, 3 p.Article

Updated survival analysis in patients with stage IIIB or IV non-small-cell lung cancer receiving BLP25 liposome vaccine (L-BLP25): phase IIB randomized, multicenter, open-label trialBUTTS, Charles; MAKSYMIUK, Andrew; FALK, Martin et al.Journal of cancer research and clinical oncology. 2011, Vol 137, Num 9, pp 1337-1342, issn 0171-5216, 6 p.Article

Retromolar trigone carcinoma treated by primary radiation therapy: An alternative to the primary surgical approachAYAD, Tareck; GELINAS, Michel; GUERTIN, Louis et al.Archives of otolaryngology, head & neck surgery. 2005, Vol 131, Num 7, pp 576-582, issn 0886-4470, 7 p.Article

Sunitinib combined with pemetrexed and cisplatin: results of a phase I dose-escalation and pharmacokinetic study in patients with advanced solid malignancies, with an expanded cohort in non-small cell lung cancer and mesotheliomaCAMIDGE, D. Ross; BLAIS, Normand; CHOW, Laura Q et al.Cancer chemotherapy and pharmacology. 2013, Vol 71, Num 2, pp 307-319, issn 0344-5704, 13 p.Article

Role of neck dissection following concurrent chemoradiation for advanced head and neck carcinomaFOREST, Véronique-Isabelle; NGUYEN-TAN, Phuc Felix; TABET, Jean-Claude et al.Head & neck. 2006, Vol 28, Num 12, pp 1099-1105, issn 1043-3074, 7 p.Article

North-American survey on HPV-DNA and p16 testing for head and neck squamous cell carcinomaMANIAKAS, Anastasios; MOUBAYED, Sami P; AYAD, Tareck et al.Oral oncology (1997). 2014, Vol 50, Num 10, pp 942-946, issn 1368-8375, 5 p.Article

OUTCOME WITH NECK DISSECTION AFTER CHEMORADIATION FOR N3 HEAD-AND-NECK SQUAMOUS CELL CARCINOMAIGIDBASHIAN, Levon; FORTIN, Bernard; GUERTIN, Louis et al.International journal of radiation oncology, biology, physics. 2010, Vol 77, Num 2, pp 414-420, issn 0360-3016, 7 p.Article

Tremelimumab in Combination with Exemestane in Patients with Advanced Breast Cancer and Treatment-Associated Modulation of Inducible Costimulator Expression on Patient T CellsVONDERHEIDE, Robert H; LORUSSO, Patricia M; USARI, Tiziana et al.Clinical cancer research (Print). 2010, Vol 16, Num 13, pp 3485-3494, issn 1078-0432, 10 p.Article

Multicenter phase II study of erlotinib, an oral epidermal growth factor receptor tyrosine kinase inhibitor, in patients with recurrent or metastatic squamous cell cancer of the head and neckSOULIERES, Denis; SENZER, Neil N; VOKES, Everett E et al.Journal of clinical oncology. 2004, Vol 22, Num 1, pp 77-85, issn 0732-183X, 9 p.Article

SIMULTANEOUS INTEGRATED BOOST USING INTENSITY-MODULATED RADIOTHERAPY COMPARED WITH CONVENTIONAL RADIOTHERAPY IN PATIENTS TREATED WITH CONCURRENT CARBOPLATIN AND 5-FLUOROURACIL FOR LOCALLY ADVANCED OROPHARYNGEAL CARCINOMACLAVEL, Sébastien; NGUYEN, David H. A; FORTIN, Bernard et al.International journal of radiation oncology, biology, physics. 2012, Vol 82, Num 2, pp 582-589, issn 0360-3016, 8 p.Article

ENTERAL FEEDING DURING CHEMORADIOTHERAPY FOR ADVANCED HEAD-AND-NECK CANCER: A SINGLE-INSTITUTION EXPERIENCE USING A REACTIVE APPROACHCLAVEL, Sébastien; FORTIN, Bernard; DESPRES, Philippe et al.International journal of radiation oncology, biology, physics. 2011, Vol 79, Num 3, pp 763-769, issn 0360-3016, 7 p.Article

Phase I/II trial of erlotinib and cisplatin in patients with recurrent or metastatic squamous cell carcinoma of the head and neck: A Princess Margaret Hospital phase II consortium and National Cancer Institute of Canada Clinical Trials Group StudySIU, Lillian L; SOULIERES, Denis; EISENHAUER, Elizabeth A et al.Journal of clinical oncology. 2007, Vol 25, Num 16, pp 2178-2183, issn 0732-183X, 6 p.Article

Phase I and pharmacokinetic study of novel L-nucleoside analog troxacitabine given as a 30-minute infusion every 21 daysBELANGER, Karl; MOORE, Malcolm; BAKER, Sharyn D et al.Journal of clinical oncology. 2002, Vol 20, Num 10, pp 2567-2574, issn 0732-183XArticle

CERVICAL LYMPH NODE METASTASES FROM UNKNOWN PRIMARY CANCER: A SINGLE-INSTITUTION EXPERIENCE WITH INTENSITY-MODULATED RADIOTHERAPYVILLENEUVE, Hugo; DESPRES, Philippe; FORTIN, Bernard et al.International journal of radiation oncology, biology, physics. 2012, Vol 82, Num 5, pp 1866-1871, issn 0360-3016, 6 p.Article

THE ROLE OF COMPUTED TOMOGRAPHY IN THE MANAGEMENT OF THE NECK AFTER CHEMORADIOTHERAPY IN PATIENTS WITH HEAD-AND-NECK CANCERCLAVEL, Sébastien; CHARRON, Marie-Pierre; BELAIR, Manon et al.International journal of radiation oncology, biology, physics. 2012, Vol 82, Num 2, pp 567-573, issn 0360-3016, 7 p.Article

Randomized, Placebo-Controlled, Double-Blind, Phase II Study of Axitinib Plus Docetaxel Versus Docetaxel Plus Placebo in Patients With Metastatic Breast CancerRUGO, Hope S; STOPECK, Alison T; BAIR, Angel H et al.Journal of clinical oncology. 2011, Vol 29, Num 18, pp 2459-2465, issn 0732-183X, 7 p.Conference Paper

A phase II study of topotecan in patients with anaplastic oligodendroglioma or anaplastic mixed oligoastrocytomaBELANGER, Karl; MACDONALD, David; EISENHAUER, Elizabeth et al.Investigational new drugs. 2003, Vol 21, Num 4, pp 473-480, issn 0167-6997, 8 p.Article

Sunitinib combined with pemetrexed and carboplatin in patients with advanced solid malignancies—results of a phase I dose-escalation studyBLAIS, Normand; CAMIDGE, D. Ross; CHOW, Laura Q et al.Investigational new drugs. 2013, Vol 31, Num 6, pp 1487-1498, issn 0167-6997, 12 p.Article

Phase III Study of Gefitinib 250 Compared With Intravenous Methotrexate for Recurrent Squamous Cell Carcinoma of the Head and NeckSTEWART, J. Simon W; COHEN, Ezra E. W; VARELLA-GARCIA, Marileila et al.Journal of clinical oncology. 2009, Vol 27, Num 11, pp 1864-1871, issn 0732-183X, 8 p.Article

Predictive and pharmacodynamic biomarker studies in tumor and skin tissue samples of patients with recurrent or metastatic squamous cell carcinoma of the head and neck treated with erlotinibAGULNIK, Mark; DA CUNHA SANTOS, Gilda; WINQUIST, Eric et al.Journal of clinical oncology. 2007, Vol 25, Num 16, pp 2184-2190, issn 0732-183X, 7 p.Article

Randomized phase IIB trial of BLP25 liposome vaccine in stage IIIB and IV non-small-cell lung cancerBUTTS, Charles; MURRAY, Nevin; DAVIS, Mary et al.Journal of clinical oncology. 2005, Vol 23, Num 27, pp 6674-6681, issn 0732-183X, 8 p.Article